These results further expand on our previous findings that activation of eNOS-NO signaling can contribute to the antiandrogen resistance in prostate cancer cells [27] by promotion of sGC-PKG-dependent growth of PCSCs. This evidence concerns the gene NOS3 and prostate carcinoma.